PATENT CLAIM ANALYSIS

Application Number: 15918645
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Reprogramming factor, in particular, by targeting natural antisense polynucleotides of a Reprogramming factor. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Reprogramming factors.

Claim (Index 5):
The oligonucleotide of  claim 1 , wherein the oligonucleotide comprises at least one modified nucleotide, said modified nucleotide selected from: a peptide nucleic acid, a locked nucleic acid (LNA), analogue, derivative, and a combination thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.59459
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13320637', '14588442', '14534323', '14814895', '14297101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8264529285201709
- 35 USC 102 Novelty (BERT): 0.5925007689783341
- Combined Prediction Score: 0.8030577125659873
- Mean Citation Score: 468.007694
- Max Citation Score: 491.61438
- Similarity Product: 487.5713967978932

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test